Literature DB >> 25601797

A critical appraisal of the updated 2014 Nice Pulmonary Hypertension Classification System.

Edmund M T Lau1, Marc Humbert2.   

Abstract

In 2013, the Fifth World Symposium on Pulmonary Hypertension (PH) was held in Nice, France. This meeting has been held every 5 years since the Second World Symposium in 1998, when the modern-day classification system of PH was initially conceived. PH is a pathophysiologic state of the pulmonary circulation characterized by an increased mean pulmonary artery pressure ≥ 25 mm Hg at rest, and can be the consequence of a variety of distinct disease entities. The rationale of a classification system for PH was to group together disease entities that share similar pathomechanisms, clinical presentation, and therapeutic approaches. Refinements of the classification system have been made at each subsequent World Symposium, reflecting the ongoing research and new knowledge acquired in the science of PH. We provide an update of the recent changes made to the PH classification system from the Nice meeting.
Copyright © 2015 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 25601797     DOI: 10.1016/j.cjca.2014.09.033

Source DB:  PubMed          Journal:  Can J Cardiol        ISSN: 0828-282X            Impact factor:   5.223


  6 in total

1.  Pulmonary capillary hemangiomatosis: a case series and review of literature.

Authors:  Mahmoud Abdelnabi; Abdallah Almaghraby; Hoda Abdelgawad; Fatma Elkafrawy; Karim Ziada
Journal:  Am J Cardiovasc Dis       Date:  2021-04-15

2.  Utilizing Network Pharmacology and Molecular Docking Integrated Surface Plasmon Resonance Technology to Investigate the Potential Targets and Mechanisms of Tripterygium wilfordii against Pulmonary Artery Hypertension.

Authors:  Shifa Wang; Yunjing Liu; Qingguo Wang; Xiufeng Xu; Tao Huang; Peikang Dong; Lide Wang; Bufan Cao; Qiuhong Jiao; Xiaodong Sun; Jingtian Li; Tao Wang
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-30       Impact factor: 2.650

3.  Pulmonary Veno-occlusive Disease and Pulmonary Hypertension in Dogs: Striking Similarities to the Human Condition.

Authors:  K R Stenmark; G M Krafsur; R M Tuder
Journal:  Vet Pathol       Date:  2016-07       Impact factor: 2.221

4.  The Use of Biophysical Flow Models in the Surgical Management of Patients Affected by Chronic Thromboembolic Pulmonary Hypertension.

Authors:  Martina Spazzapan; Priya Sastry; John Dunning; David Nordsletten; Adelaide de Vecchi
Journal:  Front Physiol       Date:  2018-03-13       Impact factor: 4.566

5.  Pulmonary Hypertension Registry of Kerala, India (PRO-KERALA): One-year outcomes.

Authors:  S Harikrishnan; Avinash Mani; Sanjay G; Ashishkumar M; Jaideep Menon; Rajesh G; R Krishna Kumar; A George Koshy; Thankachan V Attacheril; Raju George; Eapen Punnose; S M Ashraf; Arun Sr; Mohammed Cholakkal; Panniyammakal Jeemon; Stigi Joseph; Unni Govindan; Johny Joseph; Koshy Eapen; Madhu Sreedharan; Anil Kumar; K Venugopal
Journal:  Indian Heart J       Date:  2021-12-14

Review 6.  Pulmonary capillary hemangiomatosis: a focus on the EIF2AK4 mutation in onset and pathogenesis.

Authors:  Lijiang Ma; Ruijun Bao
Journal:  Appl Clin Genet       Date:  2015-08-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.